Notable
ADI-PEG 20, Venetoclax and Azacitidine in Acute Myeloid Leukemia
Primary completion pushed from May 2026 to Jan 2027
Polaris GroupPhase 1 NCT05001828 Registry history of NCT05001828 on ClinicalTrials.gov (opens the registry)
1 trial changed in the last 30 days: 0 stopped, 1 with a notable change, 0 with minor changes only.
Primary completion pushed from May 2026 to Jan 2027
Polaris GroupPhase 1 NCT05001828 Registry history of NCT05001828 on ClinicalTrials.gov (opens the registry)
| Phase 1 | 1 | |
| Phase 2 | 2 | |
| Phase 3 | 1 |
Acute Myeloid Leukemia (AML) (1) · Glioblastoma (1) · Glioma (1) · Leukemia (1) · Liver Cancer (1) · NASH / MASH (1)